Prospective, Randomized, Multicenter, Controlled Trial (TRIATHRON 1) on a New Antithrombogenic Hydrophilic Dialysis Membrane

INTRODUCTION: Hemodialysis treatment requires anticoagulation to prevent thrombosis of the dialyzer. The Hydrolink(®) (NV series; Toray) has been designed to reduce thrombotic complications by increasing membrane hydrophilic properties. Previous studies have confirmed reduced platelet activation, im...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Artif Organs
Main Authors: Ronco, Claudio, Brendolan, Alessandra, Nalesso, Federico, Zanella, Monica, De Cal, Massimo, Corradi, Valentina, Virzì, Grazia M., Ferrari, Fiorenza, Garzotto, Francesco, Lorenzin, Anna, Karopadi, Aakash N., Sartori, Marco, De Rosa, Silvia, Samoni, Sara, Husain-Syed, Faeq, Spinelli, Alessandra, Neri, Mauro, Villa, Gianluca, Alghisi, Alberta
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Clinical Trial Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6159854/
https://ncbi.nlm.nih.gov/pubmed/28569990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5301/ijao.5000608
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados